Mechanism of modified mRNA structure in COVID-19 vaccines for inducing neutralizing antibodies
The development of SARS-CoV-2 mRNA vaccines is closely linked to advancements in mRNA manufacturing technology. Structural modifications, such as replacing uridine with 1-methylpseudouridine (1mψ), enhance translation efficiency and help the mRNA evade immune detection. Lipid nanoparticles (LNPs) s...
Saved in:
Main Authors: | Sabighoh Zanjabila, Beti Ernawati Dewi |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Society for Biochemistry and Molecular Biology
2024-10-01
|
Series: | Acta Biochimica Indonesiana |
Subjects: | |
Online Access: | https://pbbmi.org/newjurnal/index.php/actabioina/article/view/121 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters
by: Yongjun Sui, et al.
Published: (2025-02-01) -
A nucleoside-modified mRNA vaccine prevents enterovirus A71 infection in mouse model
by: Fengyu Chi, et al.
Published: (2025-02-01) -
Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01) -
Germ granule-mediated mRNA storage and translational control
by: Hoang-Anh Pham-Bui, et al.
Published: (2025-12-01) -
Monoclonal Antibodies in Prevention and Early Treatment of COVID-19 in Lung Transplant Recipients: A Systematic Review and Perspective on the Role of Monoclonal Antibodies in the Future
by: David A. Van Eijndhoven, et al.
Published: (2025-02-01)